Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Changes in English medication safety indicators throughout the COVID-19 pandemic: a federated analysis of 57 million patients’ primary care records in situ using OpenSAFELY

Fisher L. et al, (2022)

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform

Zheng B. et al, (2022)

Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform

Tazare J. et al, (2022), Wellcome Open Research, 7, 142 - 142

Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records

Horne EMF. et al, (2022)

Using data science to identify unusual treatment choices in England: illustrative findings of uncommon antipsychotics Pericyazine and Promazine

MacKenna B. et al, (2022)

Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY

Green A. et al, (2022)

Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.

Bhaskaran K. et al, (2022), PLoS Med, 19

OpenSAFELY Vaccine Coverage Report - Second Doses

Curtis H. and OpenSAFELY Collaborative None., (2021)

OpenSAFELY Vaccine Coverage Report - Third/Booster Doses

Curtis H. and OpenSAFELY Collaborative T., (2021)

OpenSAFELY: Impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic

Curtis HJ. et al, (2021), Open Heart, 8

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELY

Green A. et al, (2021)

Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: a cohort study using OpenSAFELY

Hulme W. et al, (2021)

Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform

MacKenna B. et al, (2021)

Recording of “COVID-19 vaccine declined” among vaccination priority groups: a cohort study on 57.9 million NHS patients’ primary care records in situ using OpenSAFELY

Curtis H. et al, (2021)

Evaluating the impact of a very low-cost intervention to increase practices' engagement with data and change prescribing behaviour: a randomized trial in English primary care

Curtis HJ. et al, (2021), Family practice, 38, 373 - 380

Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: cohort study in OpenSAFELY using linked primary care, secondary care and death registration data

Bhaskaran K. et al, (2021)

Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an analysis of 4.3 million adults over the age of 65

Schultze A. et al, (2021)

Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY

The OpenSAFELY Collaborative None. et al, (2021)

Association between oral anticoagulants and COVID-19 related outcomes: two cohort studies

The OpenSAFELY Collaborative None. et al, (2021)

Trends in antidepressant prescribing in England

Walker AJ. et al, (2021), The Lancet Psychiatry, 8, 278 - 279

Load More